Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters.
1. Name of the issuer
TARGET HEALTHCARE REIT LIMITED
2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR9.8.6R(1)
or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006)
As (ii)
3. Name of person discharging managerial responsibilities/director
GORDON CHARLES COULL
4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
AS 3
5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest
BENEFICIAL INTEREST
6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares
ORDINARY SHARES
7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
8. State the nature of the transaction
9. Number of shares, debentures or financial instruments relating to shares acquired
11,000 ORDINARY SHARES
10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
0.024%
11. Number of shares, debentures or financial instruments relating to shares disposed
12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
13. Price per share or value of transaction
£1
14. Date and place of transaction
7/3/2013
15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
BENEFICIAL HOLDING - 11,000 0.024%
16. Date issuer informed of transaction
7/3/2013
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes
17. Date of grant
18. Period during which or date on which it can be exercised
19. Total amount paid (if any) for grant of the option
20. Description of shares or debentures involved (class and number)
21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
22. Total number of shares or debentures over which options held following notification
23. Any additional information
24. Name of contact and telephone number for queries
Kristina Murray, 0131 625 2930
Name and signature of duly authorised officer of issuer responsible for making notification
Martin Cassels, Company Secretary
Date of notification
15/03/2013
END